science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.0803386 on October 23, 2003

Published online before print October 23, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0803386v1
75/2/207    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dayyani, F.
Right arrow Articles by Meinhardt, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dayyani, F.
Right arrow Articles by Meinhardt, G.
(Journal of Leukocyte Biology. 2004;75:207-213.)
© 2004 by Society for Leukocyte Biology

Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphoma

Farshid Dayyani*,1, Anke Joeinig*, Löms Ziegler-Heitbrock{dagger},{ddagger}, Ralf Schmidmaier*, Christian Straka*, Bertold Emmerich* and Gerold Meinhardt*

* Department of Hematology and Oncology, Medical Clinic Campus Innenstadt, University of Munich, Germany;
{dagger} Clinical Cooperation Group Inflammatory Lung Diseases, Institute for Inhalationbiology, GSF and Asklepios-Fachkliniken, Gauting, Germany; and
{ddagger} Division of Immunology, University of Leicester and Department of Immunology, University Hospitals of Leicester, NHS Trust, United Kingdom

1 Correspondence: Department of Hematology and Oncology, Medical Clinic Campus Innenstadt, University of Munich, Ziemmssenstrasse 1, 80336 Munich, Germany. E-mail: dayyani{at}web.de

The CD14+CD16+ monocytes appear to be important to immune defense against infection, as these cells are very potent with respect to tumor necrosis factor (TNF) production, phagocytosis, and antigen presentation. Myeloablative high-dose chemotherapy (HDT) and subsequent autologous stem-cell transplantation (ASCT) are being used increasingly for therapy of hematological malignancies, but the pronounced immunosuppression renders the patients prone to infection. To determine the functional properties of CD14+CD16+ monocytes under these conditions, 15 patients with lymphoma or myeloma were examined. Before HDT, the ratio of CD14+CD16+ cells to the population of the classical CD14++ monocytes was 0.28 ± 0.12; this ratio changed during the course of HDT and ASCT in favor of the CD14+CD16+ monocytes to a maximum of 12.4 ± 7.8 (P<0.001) on day 3.5 ± 1.6 after transplanation (Tx) and returned to 0.11 ± 0.07 (P<0.001) after engraftment on day 11.3 ± 2.2. Although the absolute number of classical CD14++ monocytes declined to less than 1/µl at the nadir, the number of CD14+CD16+monocytes fell from 29.7 ± 9.8/µl to 4.5 ± 3.0/µl at the nadir and increased to 13.8 ± 9.8/µl at the day of discharge from the hospital. Flow cytometric analysis of phagocytosis of fluorescein isothiocyanate (FITC)-labeled Escherichia coli showed that 30 ± 10% CD14+CD16+ monocytes of patients were FITC-positive before Tx, and at engrafment, the percentage of FITC-positive cells had doubled to 60 ± 6% (healthy controls, 41±7%). When determining generation of reactive oxygen species after E. coli ingestion, the CD14+CD16+ monocytes showed a decreased response before Tx (32±12% positve cells), which increased to 53 ± 24% after ASCT. The median fluorescence intensity of human leukocyte antigen (HLA)-DR expression on the CD14+CD16+ monocytes increased from 11 ± 6 before Tx to 17 ± 11 after Tx, and the production of TNF after lipopolysaccharide showed no remarkable difference (46±13 vs. 49±14 channels). At the same time, expression of TNF and of HLA-DR showed a dramatic decrease in the CD14++ monocytes. Taken together after stem-cell Tx, the function of the CD14++ monocytes is impaired, and the functional properties of CD14+CD16+ monocytes recover, indicating that these cells may be important for defense against infections post-ASCT.

Key Words: phagocytosis • oxidative burst • TNF